Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEBE-CKD Trial
NCT03923933Phase 2Completed
- Sponsor
- Hospital General de México "Dr. Eduardo Liceaga"
- Start
- Jun 2019
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of chlorthalidone in chronic kidney disease (CKD), sponsored by Hospital General de México "Dr. Eduardo Liceaga". Started Jun 2019; status: completed.
02
Drugs
chlorthalidone
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT03923933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03923933.